People
The VanRx team is a world-class group of pharmaceutical industry professionals with the singular goal of being global leaders in sterile pharmaceutical manufacturing. Our experience, innovation and superior technology make this goal achievable.
Our spectrum of experience covers drug product development, process engineering, development/implementation of new manufacturing technology, and building and operating facilities. We have first-hand experience working with the majority of contract fill/finish sites in Europe and North America, and know what works and what doesn’t.
Management
Christopher Procyshyn | CEO
Christopher Procyshyn has extensive experience in pharmaceutics, aseptic processing and pharmaceutical manufacturing. He has directed the CMC efforts of several companies developing major late-stage sterile drug products, several with novel complex formulations. Capital projects to support clinical manufacturing have been a particular focus, with recent projects successfully yielding novel technology and facility designs for the production of sterile drug products. Christopher has a global perspective on the pharmaceutical industry, having worked at Lifecore Biomedical (JnJ), QLT and Poniard Pharmaceuticals, with manufacturing projects executed worldwide.
Christopher is a member of the Parenteral Drug Association, and is on the Board of Directors for the International Society for Pharmaceutical Engineering, Pacific Northwest Chapter. He holds a Bachelor of Science degree in Microbiology from the University of Saskatchewan.
Ross Gold, P.Eng. | President
Ross Gold has broad and diverse experience in the design and development of pharmaceutical manufacturing systems, as well as leading engineering teams in pharmaceutical companies. His experience includes API and drug product development for both clinical and commercial manufacturing. Through both corporate roles and his consulting practice, Ross has been responsible for design development and fabrication oversight for novel pharmaceutical manufacturing equipment and the planning and execution of capital projects and process technical transfers. Ross has extensive experience consulting for major biotechnology companies and CMO’s in their manufacturing engineering areas, specializing in automation systems.
Ross is a registered Professional Engineer in the province of British Columbia and a member of the International Society of Pharmaceutical Engineers. He holds a Bachelor of Science degree in Chemical Engineering from Queen’s University in Kingston, Ontario.
Strategic Advisory Board
Adrian White, FCA
Currently member of a number of boards of private companies and the board of an Ontario power distribution company. Formerly, a senior officer of one of Canada’s largest independently owned base metal exporters. The company created two brand new Canadian mining projects and listed on the New York and Toronto Stock Exchanges. Former Governor and executive of the Canadian Institute of Chartered Accountants, former member of council and executive of the Institute of Chartered Accountants of Ontario, former Chairman of the Canadian Bankers Association Task Force on Capital Adequacy and Liquidity and Past President, Financial Executives Institute (Toronto Chapter). Previously, a senior officer at a major Canadian bank, created a brand new department to raise the bank’s capital on a global basis. Involved extensively in the creation of the capital markets group of the bank, the purchase of a major investment dealer and a United States bank, and in managing the insurance industry relationships of the bank. CA 1964; FCA 1982.
James Agalloco
James Agalloco is President of Agalloco & Associates, a technical service firm to the pharmaceutical and biotechnology industry. Jim has over 35 years of industry experience and has worked in organic synthesis, pharmaceutical formulation, pharmaceutical production, project and process engineering, validation and process automation during his career at Merck, Pfizer, Squibb and Bristol-Myers Squibb. Jim holds a BS and MS in Chemical Engineering and an MBA in Pharmaceutical Studies. He is a past President of the Parenteral Drug Association and served as an Officer or Director from 1982 to 1993. He is a member of USP’s Microbiology and Sterility Assurance Expert Committee for 2005-2010. He is a member of the editorial advisory board’s of Pharmaceutical technology and Pharmaceutical Manufacturing. He is a frequent author and lecturer on the subject of sterilization, aseptic processing, isolation technology and process validation.
Sam Halaby
Sam has over twelve years experience in programming, design, and qualification of biotechnologyand pharmaceutical facilities ranging form clinical to full-scale production plants. Sam’s particular focus is in cGMP manufacturing design including process technology evaluation, capacity analysis, and cGMP environmental classification, and operational analysis. Sam draws from his compliance and process experience to create and develop functionally compliant designs, integrating owner and regulatory requirements. Sam’s experience is international and he has filled the role as project manager and process lead on major capital projects through to construction. Sam is very active in ISPE heading up the Manufacturing technology Subcommittee and is a Steering Committee Member of ISPE COP Sterile Products. Sam is recognized as a leader in fill/finish facility design and containment of highly potent compounds. Sam frequently presents and lectures on subject matters including: Fundamentals of High Hazardous (Potent) Compound Safety, Facility Design Strategies for Aseptic Manufacturing, Manufacturing Dynamics / Capacity Driven Programming, Regulatory Issues for the Biotechnology Industry, Planning, Designing and Managing Renovation Projects, Potent Compound Systems Containment Strategies.
Christopher Breikss
Chris Breikss is co-founder and President of 6s Marketing, a Vancouver based internet marketing firm that provides search engine marketing and website promotion for clients in a broad range of industries. Chris has been involved in the Internet marketing industry for over 10 years and was a pioneer in this evolving field. Chris is a sought after speaker in the industry and has lectured on Internet marketing at various conferences and venues including The University of British Columbia, E-BC and the International Internet Marketing Association. Chris is co-founder of OnRes Systems Inc., a leading software company, which was sold to Gotham OHC in 2005. Chris also co-founded and sold Discover Vancouver Enterprises a popular local tourism portal. Chris volunteers his time with the Canadian Cancer Society raising money for Art for Camp Good Times, which provides children with cancer a chance to enjoy summer camp
